Virtual Screening of Indonesian Herbal Compounds with Neuraminidase Inhibitor Activity against N2 Influenza Virus Protein: An in silico Study
Background: Neuraminidase inhibitor (NAI) is one of anti-influenza drugs recommended for use by the World Health Organization (WHO). However, after treatment with NAI drugs in human, resistance to influenza antiviral drugs is begun to rise. Therefore, identification of compounds from Indonesian herb...
Saved in:
Main Authors: | Diana Nurjanah (Author), Fadilah Fadilah (Author), Ni Luh Putu Indi Dharmayanti (Author) |
---|---|
Format: | Book |
Published: |
Cell and BioPharmaceutical Institute,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022) -
Virtual screening of Indonesian herbal compounds as COVID-19 supportive therapy: machine learning and pharmacophore modeling approaches
by: Linda Erlina, et al.
Published: (2022) -
Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus
by: Jawaria Khan, et al.
Published: (2017) -
Anti-neuraminidase immunity in the combat against influenza
by: Xiaojian Zhang, et al.
Published: (2024) -
Non-Analog Compounds to Sialic Acid as Inhibitors of Influenza Virus Neuraminidase: An Underexplored Approach for Novel Antivirals-Systematic Review
by: Luis Márquez-Domínguez, et al.
Published: (2024)